Search results
1 day ago · Website. Genentech, a key member of the Roche Group, has officially announced the reintroduction of Susvimo (ranibizumab injection) 100 mg/mL, a cutting-edge treatment for wet, or neovascular, age-related macular degeneration (AMD) in the United States. This comes after a voluntary recall and subsequent approval by the U.S.
1 day ago · Mit unserem E-Banking erledigen Sie Ihre Bankgeschäfte bequem, einfach und sicher von zuhause aus.
